跳至主要内容
临床试验/NCT06259656
NCT06259656已完成不适用

Antibody Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.

Vachira Phuket Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Level

研究概览

简要总结

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV.

详细描述

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV. Sample size is 40 Thai patients at labor room Vachira Phuket Hospital in October - November 2023, who have at least one COVID-19 vaccination before or when pregnant. The Secondary outcome is to study time effect after COVID-19 vaccination and effect of vaccine type on Antibody level.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Thai term pregnant women
  • 18-45 year old
  • At least 1 covid vaccination received
  • admission at Vachira Phuket Hospital Labor Room

排除标准

  • Do not want to participate
  • Unstable or Emergency condition

结局指标

主要结局

COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Level

时间窗: 1 month

Test for correlation of level in maternal and cord blood

次要结局

  • Analysed time effect from last vaccination and type.(1 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Correlation of Antibody Response to COVID-19... | 临床试验